Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,957 public trials 633 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

NCT02443324

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Biliary Tract Cancer, Biliary Tract Diseases, +32 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists and Research Institute St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Chattanooga, Tennessee, United States
View all 22 locations
View Trial Details
Completed

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT02773849

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Keck School of Medicine at USC Medical Center Los Angeles, California, United States
  • The Urology Center of Colorado Denver, Colorado, United States
  • University of Florida - UF Health Davis Center Pavilion and Shands Med Plaza Gainesville, Florida, United States
View all 34 locations
View Trial Details
Completed

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

NCT03513952

Conditions
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
Locations
  • Kaiser Permanente-Riverside Riverside, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Straub Clinic and Hospital Honolulu, Hawaii, United States
  • University of Hawaii Cancer Center Honolulu, Hawaii, United States
View Trial Details
Completed

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

NCT02091141

Conditions
Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +16 more
Locations
  • Western Regional Medical Center at Cancer Treatment Centers of America Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Science 37, Inc Culver City, California, United States
View all 60 locations
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details

Related conditions